Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)
China flag China · Delayed Price · Currency is CNY
29.56
-0.16 (-0.54%)
Nov 19, 2024, 9:49 AM CST

Hubei Jumpcan Pharmaceutical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
8,9069,6388,9767,6186,1516,922
Upgrade
Other Revenue
16.5116.5119.871314.2518.32
Upgrade
Revenue
8,9239,6558,9967,6316,1656,940
Upgrade
Revenue Growth (YoY)
-7.43%7.32%17.90%23.77%-11.17%-3.72%
Upgrade
Cost of Revenue
1,7911,7841,5371,2771,1301,110
Upgrade
Gross Profit
7,1317,8717,4596,3545,0355,830
Upgrade
Selling, General & Admin
3,8734,3794,4774,0313,3003,707
Upgrade
Research & Development
426.66464.4553.3523.44243.75210.14
Upgrade
Other Operating Expenses
125.59146.24138.81120.999.9109.68
Upgrade
Operating Expenses
4,4134,9875,2054,6833,6504,027
Upgrade
Operating Income
2,7182,8842,2541,6711,3851,803
Upgrade
Interest Expense
-30.34-17.58-30.41-34.9-33.03-30.74
Upgrade
Interest & Investment Income
359.96357.81183.21171.4283.0364.84
Upgrade
Other Non Operating Income (Expenses)
77.9-0.83-1.2-0.41-0.58-0.65
Upgrade
EBT Excluding Unusual Items
3,1263,2232,4051,8071,4351,836
Upgrade
Gain (Loss) on Sale of Investments
85.5314.6-7.32114.5520.9410.59
Upgrade
Gain (Loss) on Sale of Assets
0.220.135.220.653.350.3
Upgrade
Asset Writedown
-1.09-1.09-0.53-0.42-0.77-1.96
Upgrade
Other Unusual Items
60.4260.42105.0928.9625.3748.24
Upgrade
Pretax Income
3,2713,2972,5081,9501,4841,893
Upgrade
Income Tax Expense
483.98470.03336.2233.22206.29270.17
Upgrade
Earnings From Continuing Operations
2,7872,8272,1721,7171,2771,623
Upgrade
Minority Interest in Earnings
-5.58-4.28-0.971.96--
Upgrade
Net Income
2,7812,8232,1711,7191,2771,623
Upgrade
Net Income to Common
2,7812,8232,1711,7191,2771,623
Upgrade
Net Income Growth
10.25%30.04%26.27%34.60%-21.30%-3.84%
Upgrade
Shares Outstanding (Basic)
919916890886835816
Upgrade
Shares Outstanding (Diluted)
919916908900835816
Upgrade
Shares Change (YoY)
-0.20%0.91%0.91%7.82%2.36%0.02%
Upgrade
EPS (Basic)
3.033.082.441.941.531.99
Upgrade
EPS (Diluted)
3.033.082.391.911.531.99
Upgrade
EPS Growth
10.47%28.87%25.13%24.84%-23.12%-3.86%
Upgrade
Free Cash Flow
2,1363,1622,3771,6461,3521,601
Upgrade
Free Cash Flow Per Share
2.323.452.621.831.621.96
Upgrade
Dividend Per Share
1.3001.3000.8800.6800.4501.230
Upgrade
Dividend Growth
47.73%47.73%29.41%51.11%-63.41%0%
Upgrade
Gross Margin
79.92%81.52%82.91%83.27%81.67%84.00%
Upgrade
Operating Margin
30.47%29.87%25.05%21.89%22.47%25.97%
Upgrade
Profit Margin
31.17%29.24%24.13%22.53%20.72%23.39%
Upgrade
Free Cash Flow Margin
23.94%32.75%26.42%21.57%21.93%23.07%
Upgrade
EBITDA
3,0073,1802,5611,9641,6662,035
Upgrade
EBITDA Margin
33.70%32.94%28.47%25.73%27.03%29.32%
Upgrade
D&A For EBITDA
289.01296.78307.14293.13280.95232.5
Upgrade
EBIT
2,7182,8842,2541,6711,3851,803
Upgrade
EBIT Margin
30.47%29.87%25.05%21.89%22.47%25.97%
Upgrade
Effective Tax Rate
14.80%14.26%13.41%11.96%13.91%14.27%
Upgrade
Revenue as Reported
8,9239,6558,9967,6316,1656,940
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.